Skip to main content

Table 5 Evaluation of maximal oxygen consumption and pulmonary functions

From: Effect of EMG-biofeedback robotic-assisted body weight supported treadmill training on walking ability and cardiopulmonary function on people with subacute spinal cord injuries – a randomized controlled trial

 

RABWSTT group

Control group

Maximal oxygen consumption (L/kg/min)

 Baseline

25.7 ± 7.16

20.5 ± 2.93

 Posttreatment

26.4 ± 6.99

20.5 ± 2.84

Overall within-group effect: p = 0.012*; overall between-group effect: p = 0.057; time X group interaction: p = 0.014*

Peak expiratory flow (L)

 Baseline

5.0 ± 2.34

4.7 ± 2.34

 Posttreatment

5.7 ± 2.25

4.7 ± 2.58

Overall within-group effect: p = 0.077; overall between-group effect: p = 0.584; time X group interaction: p = 0.048*

Forced expiratory volume in first second (FEV1)

 Baseline

2.2 ± 0.81

2.2 ± 0.81

 Posttreatment

2.4 ± 0.94

2.2 ± 0.91

Overall within-group effect: p = 0.204; overall between-group effect: p = 0.792; time X group interaction: p = 0.104

Forced vital capacity (L)

 Baseline

2.7 ± 1.30

2.6 ± 0.75

 Posttreatment

2.7 ± 1.26

2.6 ± 0.93

Overall within-group effect: p = 0.360; overall between-group effect: p = 0.849; time X group interaction: p = 0.872

  1. RABWSTT: Robotic-assisted body weight supported treadmill training; *: p-value< 0.05